WuXi Biologics (Cayman), Inc. (WXIBF)
6.77
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
WuXi Biologics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Repligen Corp. | 4.675 |
| Sinovac Biotech Ltd. | 0.8525 |
| Bio-Techne Corp. | 5.364 |
| CASI Pharmaceuticals, Inc. | -- |
| BioLife Solutions, Inc. | 4.494 |
Price to Book Value Related Metrics
| PE Ratio | 39.71 |
| PS Ratio | 8.363 |
| PEG Ratio | 0.3793 |
| Price to Free Cash Flow | 44.92 |
| Price | 6.77 |
| Earnings Yield | 2.52% |
| Market Cap | 27.80B |
| PEGY Ratio | 0.3793 |
| Operating PE Ratio | 25.84 |
| Normalized PE Ratio | 42.29 |